Mereo BioPharma Group plc Sponsored ADR $(MREO)$ is currently at $4.09, down $0.41 or 9.11%
--Would be lowest close since Aug. 15, 2024, when it closed at $4.08
--On pace for largest percent decrease since Aug. 29, 2023, when it fell 12.57%
--Currently down four of the past five days
--Down 12.79% month-to-date
--Up 77.06% year-to-date
--Down 37.08% from its all-time closing high of $6.50 on April 24, 2019
--Up 178.23% from 52 weeks ago (Sept. 19, 2023), when it closed at $1.47
--Down 16.02% from its 52-week closing high of $4.87 on Aug. 26, 2024
--Up 245.15% from its 52-week closing low of $1.19 on Oct. 4, 2023
--Traded as low as $4.05
--Down 10% at today's intraday low; largest intraday percent decrease since Aug. 5, 2024, when it fell as much as 13.44%
All data as of 1:38:55 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 17, 2024 13:42 ET (17:42 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.